• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • In the news: Health

    Oxfam to Global Fund: Stop malaria program

    The Global Fund to Fight AIDS, Tuberculosis and Malaria’s international Board will meet Nov. 14 and 15 to consider whether a contentious pilot program to distribute malaria medicines through local private providers who are not health workers should continue.

    By Amy Lieberman // 25 October 2012
    A man prepares artemisinin combination therapy treatment. Oxfam International believes that the Affordable Medicins Facility for malaria program is operating at a "risky" cost. Photo by: Novartis AG / CC BY-NC-ND

    The Global Fund to Fight AIDS, Tuberculosis and Malaria’s international Board will meet Nov. 14 and 15 to consider whether a contentious pilot program to distribute malaria medicines through local private providers who are not health workers should continue.

    Oxfam International believes the Global Fund should put an end to the Affordable Medicines Facility for malaria program, which subsidizes the cost of artemisinin combination therapy treatments and encourages its sale in the private sector.

    In a report released Oct. 24, Oxfam said AMFm is operating at a “risky” cost, increasing the possibility of misdiagnosis and causing excessive orders of ACT treatments.

    In a statement to the BBC, the Global Fund dismissed Oxfam’s claims as “simply untrue,” stressing that AMFm has made high-quality malaria medicines available to more people at significantly lower prices.

    “Some Western aid groups oppose a pragmatic approach that includes any involvement of the private sector,” it said. “Before the launch of AMFm, life-saving malaria treatments cost up to 20 times as much.”

    The Global Fund released the results of an independent evaluation of the program’s pilot phase early this month. The report notes that although some benchmarks were met, the level of success varied among the eight pilot areas. Further, while the program’s impact on the private for-profit sector has been a “game changer,” it had a limited influence on the public sector.

    The program, launched in 2009, has been piloted in eight countries and has subsidized more than 300 million ACT treatments. Its pilot phase is set to conclude in December 2012.

    Read more development aid news online, and subscribe to The Development Newswire to receive top international development headlines from the world’s leading donors, news sources and opinion leaders — emailed to you FREE every business day.

    • Global Health
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Amy Lieberman

      Amy Liebermanamylieberman

      Amy Lieberman is an award-winning journalist based in New York City. Her coverage on politics, social justice issues, development and climate change has appeared in a variety of international news outlets, including The Guardian, Slate and The Atlantic. She has reported from the U.N. Headquarters, in addition to nine countries outside of the U.S. Amy received her master of arts degree from the Columbia University Graduate School of Journalism in May 2014. Last year she completed a yearlong fellowship on the oil industry and climate change and co-published her findings with a team in the Los Angeles Times.

    Search for articles

    Related Stories

    Devex CheckUpDevex CheckUp: $1.4B Global Fund cuts hit over 100 countries

    Devex CheckUp: $1.4B Global Fund cuts hit over 100 countries

    Global Health‘Disaster’ as health programs reel from USAID terminations

    ‘Disaster’ as health programs reel from USAID terminations

    Malaria'Malaria thrives on chaos' — and the US aid freeze is creating it

    'Malaria thrives on chaos' — and the US aid freeze is creating it

    MalariaIs the world on track to eradicate malaria?

    Is the world on track to eradicate malaria?

    Most Read

    • 1
      The power of diagnostics to improve mental health
    • 2
      Lasting nutrition and food security needs new funding — and new systems
    • 3
      Opinion: Urgent action is needed to close the mobile gender gap
    • 4
      Supporting community-driven solutions to address breast cancer
    • 5
      How to use law to strengthen public health advocacy
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement